Publications
- BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS2023 | Publication without faculty affiliation
- Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides2022 | Publication without faculty affiliation
- Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents2022 | Publication without faculty affiliation
- Development of versatile and potent monoquaternary reactivators of acetylcholinesterase2021 | Publication without faculty affiliation
- Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase2019 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes2023 | Faculty of Pharmacy in Hradec Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Faculty of Pharmacy in Hradec Králové
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Faculty of Pharmacy in Hradec Králové
Loading network view...